France vs Malta: Cause of death, by non-communicable diseases, ages 15-59, male
France
73.4%
in 2021
Malta
74.9%
in 2021
France rank
17th
Malta rank
14th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- France
- Malta
How they compare
Malta currently reports 74.9% against 73.4% in France, a difference of 1.5%.
Across all 6 years both countries report, Malta has been ahead every year.
France ranks 17th and Malta ranks 14th of 185 countries.
Malta has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | France | Malta | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 71.7% | 77.3% | 5.5% | Malta |
| 2010s | 75.6% | 77.1% | 1.5% | Malta |
| 2020s | 72.8% | 74.7% | 1.9% | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, France or Malta?
- Malta, at 74.9% against 73.4% in France as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between France and Malta?
- 1.5%, with Malta ahead.
- How many years of comparable data are there for France and Malta?
- 6 years are reported by both, from 2000 to 2021.
- How do France and Malta rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- France ranks 17th and Malta ranks 14th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.